Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: FlowSoFine - A tool for analyzing microbial pattern changes detected by flow cytometry

PROVIDER: PRJEB49389 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR7720430.fastq.gz	Fastqsanger.gz
	ERR7720440.fastq.gz	Fastqsanger.gz
	ERR7720450.fastq.gz	Fastqsanger.gz
	ERR7720460.fastq.gz	Fastqsanger.gz
	ERR7720470.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 161

Similar Datasets

undefined

Project description:Flow cytometry as a methanogen monitoring tool

| PRJEB53907 | ENA

Project description:Flow Cytometry a tool for understanding the behaviour of Polyhydroxyalkanoates accumulators

| PRJNA858787 | ENA

ChIP-Seq (H3K4me3, H3K27me3) of steady-state splenic classical dendritic cells from wild type, germ-free and IFNAR knockout mice

Project description:The epigenetic state of splenic cDCs from Wild Type (WT) mice, Germ Free (GF) and mice deficient for the Ifnar1 gene (IFNAR) was characterized by analyzing the occupancy of a major activating histone mark (H3K4me3) and a major repressive histone mark (H3K27me3). Splenic cDCs (CD3- CD19- CD45+ MHC-II+ CD11c+) were sorted to high purity by flow cytometry and subject to chromatin immunoprecipitation.

2018-06-30 | E-MTAB-5234 | biostudies-arrayexpress

Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia

Project description:Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML). However, MRD cannot be detected in many patients using current methods. We developed a highly sensitive 5-hydroxymethylcytosine (5hmC) signature in cell-free DNA by analyzing 115 AML patients and 86 controls. The 5hmC method detected MRD in 20 of 29 patients with negative MRD by multiparameter flow cytometry and 11 of 14 patients with negative MRD by molecular methods. MRD detection by the 5hmC method was significantly associated with relapse-free survival. This novel method can be used in most AML patients and may significantly impact AML patient management.

2023-12-31 | GSE237057 | GEO

Effect of rBC2LCN on human embryonic stem cells

Project description:We show a recombinant lectin probe, rBC2LCN, is a new tool for fluorescence-based imaging and flow cytometry analysis of human pluripotent stem cells, as an alternative to conventional pluripotent maker antibodies. Live or fixed colonies of both human embryonic stem cells and induced pluripotent stem cells were visualized using fluoresceinated rBC2LCN. Fluoresceinated rBC2LCN also separated live pluripotent stem cells from mixed cell population by flow cytometry.

2015-12-09 | GSE42976 | GEO

Paramecium tetraurelia strain:51

Project description:Paramecium flow cytometry-based nucleus purification

| PRJNA327166 | ENA

variovorax paradoxus

Project description:Ecological stability properties of microbial communities assessed by flow cytometry

| PRJNA407269 | ENA

HCT116 colorectal cancer cells treated with 2.5 mM Metformin

Project description:Metformin is a drug used in the treatment of type 2 diabetes mellitus. Various studies have elucidated its anticancer properties. In this study, the effect of metformin on the differentiation and tumor microenvironment of colorectal cancer cells (CRC) was evaluated. For our study, we have used HCT116 colorectal cancer cell line and treated the cells with Metformin. Maximum tolerable non-toxic dose of metformin on HCT116 cells was determined by MTT assay. Cells were treated with 2.5 mM Metformin for 2 weeks. Analysis of apoptosis was done by flow cytometry using Annexin V / PI. CSC population was determined by flow cytometry using CSC markers CD44 and CD166. Metformin's ability to induce differentiation in CSC was assessed by analyzing Cytokeratin 20 (CK20) by flow cytometry and CDX1 (transcription factor for CK20), by RT-QPCR. Expression of Ki67 (proliferation marker) was done by RT-QPCR. RNA was isolated from 2.5 mM Metformin-treated and untreated cells populations. Microarray of untreated and 2.5 mM Metformin-treated RNA was done to study the whole genome transcriptomic changes.

2024-04-05 | GSE171478 | GEO

marine metagenome

Project description:CARBOM cruise 2013 flow cytometry sorted phytoplankton

| PRJNA377956 | ENA

Investigation of flow cytometry for analysis of mouse brain

Project description:The brain is difficult to analyze using flow cytometry because of its complex interactions of cells, high lipid content, and high autofluorescence. In this study, we investigated methods to isolate various types of brain cells with high yields and viability. The results showed that proteinase selection had a significant effect on the viability of various types of cells in the brain. The differences in the developmental stage also affected cell yield and viability. Moreover, the intensity of autofluorescence was found to differ greatly among the various regions of the brain. We also searched for neuronal markers that recognize a wide range of neurons. The ratios of the various exosomes contained by neurons differed depending on the type of neuronal marker. We also developed a method to quantify microglial phagocytosis in large quantities and in a short time using flow cytometry. These results have revealed critical factors that must be considered when analyzing various types of brain cells using flow cytometry.

2025-07-09 | GSE278315 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data